• Vanda Pharmaceuticals will release third-quarter 2026 financial results on October 28, 2026, following the market close.
• Management will discuss results and corporate activities during a conference call with a simultaneous webcast on October 28, 2026, at 4:30 p.m. ET.
• A call replay will be available from October 28, 2026, at 8:30 p.m. ET through November 4, 2026, at 11:59 p.m. ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610211740PR_NEWS_USPR_____PH78433) on October 21, 2026, and is solely responsible for the information contained therein.